Beijing, Beijing, China In 2015 was created Miaoshou Doctor, which is appeared as Corporate Investor. The venture was found in Asia in China. The leading representative office of defined Corporate Investor is situated in the Beijing.
The fund was created by Tao He.
The typical case for the fund is to invest in rounds with 4 participants. The meaningful sponsors for the fund in investment in the same round are Yi Fang Group, Midas Capital, Long Hill Capital.
For fund there is a match between the location of its establishment and the land of its numerous investments - China. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight VCBeat, UmerDoctor. We can highlight the next thriving fund investment areas, such as Media and Entertainment, Health Care.
The common things for fund are deals in the range of 1 - 5 millions dollars. The high activity for fund was in 2019. The fund is constantly included in less than 2 deals per year.
| Fund Name | Location |
| 51 Blue Stone Ln | - |
| Bridge One | Brazil, São Paulo, Sao Paulo |
| European Life Sciences Growth Fund | - |
| Global Growth Capital | England, London, United Kingdom |
| InSite | California, Redondo Beach, United States |
| Kikuchi Seisakusho | Hachioji, Japan |
| MedVest Fund II | - |
| Ontario Bioscience Industry Organization | Canada, Ontario, Toronto |
| Rochester Advisors | New York, Pittsford, United States |
| SG INCUBATE | Fukuoka, Fukuoka Prefecture, Japan |
| SourceN | Bangalore, India, Karnataka |
| Spakur Finance | - |
| Station 13 | - |
| Swing Ventures | New York, New York, United States |
| The Chiba Kogyo Bank | Chiba, Chiba Prefecture, Japan |
| Trellis Health Ventures | California, San Francisco, United States |
| Vis Mundi | Dubai, United Arab Emirates |
| Vision Plus Capital | China, Hangzhou, Zhejiang |
| Zhuhai Hengqin Shijing Touzi Hehuoqiye (Limited Partnership) | China, Guangdong, Zhuhai |
| Zhuifeng Touzi | China, Hangzhou, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
UmerDoctor | $3M | 25 Jan 2019 | Shanghai, Shanghai, China | ||
| $2M | 16 Nov 2018 | China, Beijing |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
UmerDoctor | $3M | 25 Jan 2019 | Shanghai, Shanghai, China | ||
| $2M | 16 Nov 2018 | China, Beijing |
